Subgroup analysis by prior non-liposomal irinotecan therapy in NAPOLI-1: A phase 3 study of nal-IRI±5-fluorouracil/leucovorin in patients with metastatic pancreatic ductal adenocarcinoma previously treated with gemcitabine-based therapy.
Authors
Blanc, JHubner, Richard A
Li, C
Wang-Gillam, A
Bodoky, G
Dean, A
Shan, Y
Jameson, G
Macarulla, T
Lee, K
Cunningham, D
Chiu, C
Schwartsmann, G
Braiteh, F
Von Hoff, D
Chen, L
Mamlouk, K
Bhargava, P
de Jong, F
Siveke, J
Affiliation
Hospital Haut-Leveque, Bordeaux, FranceIssue Date
2017-06
Metadata
Show full item recordCitation
Subgroup analysis by prior non-liposomal irinotecan therapy in NAPOLI-1: A phase 3 study of nal-IRI±5-fluorouracil/leucovorin in patients with metastatic pancreatic ductal adenocarcinoma previously treated with gemcitabine-based therapy 2017, 28 (suppl_3) Ann OncolJournal
Annals of OncologyDOI
10.1093/annonc/mdx263.017Type
Meetings and ProceedingsLanguage
enISSN
0923-75341569-8041
ae974a485f413a2113503eed53cd6c53
10.1093/annonc/mdx263.017